From March 26, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 27, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.34 CNY | +0.70% | +2.83% | -2.76% |
03:11pm | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
05-07 | US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.76% | 7.99B | |
+32.59% | 698B | |
+26.51% | 568B | |
-4.62% | 358B | |
+19.03% | 328B | |
+3.54% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.16% | 165B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Tranche Update on Shanghai Fosun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2024.